IRAK1 and hematologic disorder: As such, constitutive activation of the IL-1R pathway and its fundamental signal transducer proteins (interleukin-1 receptor-associated kinase 1, IRAK1; myeloid differentiation primary response 88 protein, MYD88) has been demonstrated in several hematological malignancies [28].